rxstatShortages › Fesoterodine

Fesoterodine (Toviaz) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 13, 2026

Some Fesoterodine products are in shortage in Canada (1 of 4 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 10, 2027.

An antimuscarinic used to treat overactive bladder with urgency and frequent urination.

Products affected
1 / 4
In shortage since
Feb 9, 2026
Est. full return
Dec 10, 2027
Reports on file
14
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
SANDOZ FESOTERODINE FUMARATE
8MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02521776 · since Feb 9, 2026, est. end Dec 10, 2027 · Disruption of the manufacture of the drug.
Resolved
SANDOZ FESOTERODINE FUMARATE
8MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02521776 · ended Nov 21, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ FESOTERODINE FUMARATE
4MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02521768 · ended Oct 31, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ FESOTERODINE FUMARATE
4MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02521768 · ended Aug 11, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
SANDOZ FESOTERODINE FUMARATE
4MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02521768 · ended Feb 17, 2025 · Delay in shipping of the drug.
Resolved
SANDOZ FESOTERODINE FUMARATE
8MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02521776 · ended Dec 23, 2024 · Requirements related to complying with good manufacturing practices.
Resolved
SANDOZ FESOTERODINE FUMARATE
8MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02521776 · ended Dec 16, 2024 · Disruption of the manufacture of the drug.
Resolved
SANDOZ FESOTERODINE FUMARATE
4MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02521768 · ended Dec 16, 2024 · Delay in shipping of the drug.
Resolved
SANDOZ FESOTERODINE FUMARATE
8MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02521776 · ended Sep 9, 2024 · Delay in shipping of the drug.
Resolved
SANDOZ FESOTERODINE FUMARATE
4MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02521768 · ended Sep 3, 2024 · Delay in shipping of the drug.
Resolved
SANDOZ FESOTERODINE FUMARATE
4MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02521768 · ended Dec 14, 2022 · Demand increase for the drug.
Resolved
TOVIAZ
8MG · TABLET (EXTENDED-RELEASE) · PFIZER CANADA ULC
DIN 02380048 · ended Sep 30, 2022 · Disruption of the manufacture of the drug.

Showing 12 of 14 reports. All reports are on file with Health Canada.

What's happening

Fesoterodine is currently affected by an active shortage report filed with Health Canada by SANDOZ CANADA INCORPORATED.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Fesoterodine is classified under “OTHER UROLOGICALS, INCL ANTISPASMODICS” (ATC G04BD).

Recent changes

Common questions

What is Fesoterodine used for?

An antimuscarinic used to treat overactive bladder with urgency and frequent urination.

When will Fesoterodine be back in stock in Canada?

The latest manufacturer estimate is Dec 10, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Fesoterodine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (other urologicals, incl antispasmodics)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.